Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xenoport Inc (NASDAQ:XNPT)

7.02
Delayed Data
As of Jun 28
 +0.01 / +0.14%
Today’s Change
3.35
Today|||52-Week Range
7.86
+27.87%
Year-to-Date
No recent news for Xenoport Inc.

Today’s Trading

Previous close7.01
Today’s open7.02
Day’s range7.01 - 7.02
Volume467,311
Average volume (3 months)1,314,587
Market cap$445.3M
Dividend yield--
Data as of 4:00pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)-60.49%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-12.18%
P/E ratioNM
Price/Sales8.43
Price/Book21.89

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc+0.79+6.78%
OTICOtonomy Inc+0.75+5.02%
SPPISpectrum Pharmaceuti...+0.19+3.00%
RPTPRaptor Pharmaceutica...+0.21+4.17%
Data as of 4:00pm ET, 06/28/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$41.2M
Annual profit (last year)-$82.3M
Net profit margin-199.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Vincent J. Angotti
Chief Financial Officer &
Senior VP-Finance
William G. Harris
Corporate headquarters
Santa Clara, California

Forecasts

Partner Offers

Search for Jobs